» Articles » PMID: 13679408

Differential Roles of MGluR1 and MGluR5 in Brief and Prolonged Nociceptive Processing in Central Amygdala Neurons

Overview
Journal J Neurophysiol
Specialties Neurology
Physiology
Date 2003 Sep 19
PMID 13679408
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The laterocapsular division of the central nucleus of the amygdala (CeA) is now defined as the "nociceptive amygdala" because of its high content of neurons that respond to painful stimuli. The majority of these neurons become sensitized in a model of arthritis pain. Here we address the role of G protein-coupled group I metabotropic glutamate receptor subtypes mGluR1 and mGluR5 in nociceptive processing under normal conditions and in pain-related sensitization. Extracellular single-unit recordings were made from 65 CeA neurons in anesthetized rats. Each neuron's responses to brief mechanical stimuli, background activity, receptive field size, and threshold were measured before and after induction of the kaolin/carrageenan mono-arthritis in one knee and before and during applications of agonists and antagonists into the CeA by microdialysis. All neurons received excitatory input from the knee(s) and responded most strongly to noxious stimuli. Before arthritis, a group I mGluR1 and mGluR5 agonist (DHPG, n = 10) potentiated the responses to innocuous and noxious stimuli. This effect was mimicked by an mGluR5 agonist (CHPG, n = 15). In the arthritis pain state (>6 h after induction), the facilitatory effects of DHPG (n = 9), but not CHPG (n = 7), increased. An mGluR1 antagonist (CPCCOEt) had no effect before arthritis (n = 12) but inhibited the responses of sensitized neurons in the arthritis pain state (n = 8). An mGluR5 antagonist (MPEP) inhibited brief nociceptive responses under normal conditions (n = 19) and prolonged nociception in arthritis (n = 8). These data suggest a change of mGluR1 function and activation in the amygdala in pain-related sensitization, whereas mGluR5 is involved in brief as well as prolonged nociception.

Citing Articles

Metabotropic Glutamate Receptor 5: A Potential Target for Neuropathic Pain Treatment.

Manengu C, Zhu C, Zhang G, Tian M, Lan X, Tao L Curr Neuropharmacol. 2024; 23(3):276-294.

PMID: 39411936 PMC: 11808587. DOI: 10.2174/1570159X23666241011163035.


Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors.

Mazzitelli M, Presto P, Antenucci N, Meltan S, Neugebauer V Cells. 2022; 11(16).

PMID: 36010684 PMC: 9406805. DOI: 10.3390/cells11162608.


A compendium of validated pain genes.

Wistrom E, Chase R, Smith P, Campbell Z WIREs Mech Dis. 2022; 14(6):e1570.

PMID: 35760453 PMC: 9787016. DOI: 10.1002/wsbm.1570.


Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain.

Yakhnitsa V, Ji G, Hein M, Presto P, Griffin Z, Ponomareva O Front Pharmacol. 2022; 13:903978.

PMID: 35694266 PMC: 9177060. DOI: 10.3389/fphar.2022.903978.


Sphingosine-1-phosphate receptor 1 agonist SEW2871 alters membrane properties of late-firing somatostatin expressing neurons in the central lateral amygdala.

Mork B, Lamerand S, Zhou S, Taylor B, Sheets P Neuropharmacology. 2021; 203:108885.

PMID: 34798130 PMC: 8672675. DOI: 10.1016/j.neuropharm.2021.108885.